UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 96 filers reported holding UTAH MED PRODS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $538,000 | +2.3% | 6,210 | -0.5% | 0.00% | 0.0% |
| Q4 2020 | $526,000 | +1.5% | 6,244 | -3.8% | 0.00% | 0.0% |
| Q3 2020 | $518,000 | -13.1% | 6,491 | -3.5% | 0.00% | 0.0% |
| Q2 2020 | $596,000 | -1.0% | 6,725 | +5.1% | 0.00% | 0.0% |
| Q1 2020 | $602,000 | -16.2% | 6,396 | -3.9% | 0.00% | 0.0% |
| Q4 2019 | $718,000 | +23.2% | 6,657 | +9.5% | 0.00% | 0.0% |
| Q3 2019 | $583,000 | +7.0% | 6,082 | +6.8% | 0.00% | 0.0% |
| Q2 2019 | $545,000 | +8.6% | 5,693 | +0.2% | 0.00% | – |
| Q1 2019 | $502,000 | +15.4% | 5,684 | +8.5% | 0.00% | – |
| Q4 2018 | $435,000 | -22.6% | 5,238 | -12.3% | 0.00% | -100.0% |
| Q3 2018 | $562,000 | -18.8% | 5,970 | -5.0% | 0.00% | 0.0% |
| Q2 2018 | $692,000 | +2.5% | 6,285 | -7.9% | 0.00% | 0.0% |
| Q1 2018 | $675,000 | +19.7% | 6,825 | -1.5% | 0.00% | – |
| Q4 2017 | $564,000 | – | 6,930 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Clean Yield Group | 27,445 | $2,581,000 | 1.23% |
| Ranger Investment Management | 65,861 | $6,194,000 | 0.54% |
| ISTHMUS PARTNERS, LLC | 13,307 | $1,252,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 71,614 | $6,735,000 | 0.38% |
| AFFINITY INVESTMENT ADVISORS, LLC | 7,331 | $689,000 | 0.35% |
| Cardinal Capital Management | 10,270 | $965,000 | 0.32% |
| Ancora Advisors LLC | 62,319 | $5,861,000 | 0.27% |
| THB ASSET MANAGEMENT | 8,518 | $801,000 | 0.25% |
| Penobscot Investment Management Company, Inc. | 4,000 | $376,000 | 0.09% |
| ProShare Advisors LLC | 123,764 | $11,640,000 | 0.08% |